Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services yesterday released states’ anticipated timelines to begin renewing eligible Medicaid enrollments and terminating others after the COVID-19 public health emergency.
The U.S. District Court for the District of Connecticut this week largely dismissed a lawsuit alleging that Yale New Haven Hospital violated its fiduciary duties by selecting a retirement plan with excessive fees or poorly performing investments. The court allowed certain ancillary claims related…
In comments submitted today, AHA encouraged the Department of Health and Human Services to finalize as written its proposed rule regarding statutory conscience protections.
The Cybersecurity & Infrastructure Security Agency this week released recommendations to help health care and other critical infrastructure organizations protect their networks from malicious cyber actions, based on a simulated attack the agency conducted against an organization at its request…
The Patient-Centered Outcomes Research Institute has selected 42 health systems to participate in a $50 million multiyear initiative to implement evidence-based strategies in health care delivery.
Fifty national organizations, including the AHA, today launched the Coalition for Trust in Health & Science to combat misinformation and help Americans make science-based health decisions for themselves, their families and communities.
The Biden Administration today released a National Cybersecurity Strategy that seeks to strengthen collaboration with stakeholders to defend critical infrastructure; disrupt and dismantle threat actors; shape market forces to drive security and resilience; invest in a resilient future; and forge…
For Women’s History Month, we turn the spotlight to a female-led venture capital firm that is out to change women’s lives for the better.
AHA’s American Organization for Nursing Leadership affiliate today released the last section in its three-part compendium of best practices to manage nursing workforce complexities.
A Food and Drug Administration advisory committee this week recommended the agency approve the first two vaccines to prevent lower respiratory tract disease caused by respiratory syncytial virus in Americans aged 60 and older.